National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 611992

History of Changes from the VAERS Wayback Machine

First Appeared on 12/14/2015

VAERS ID: 611992
VAERS Form:
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 0 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 0 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 9/14/2017

VAERS ID: 611992 Before After
VAERS Form:(blank) 1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 0 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 0 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 2/14/2018

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 6/14/2018

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 8/14/2018

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 9/14/2018

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 10/14/2018

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 12/24/2020

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 12/30/2020

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 5/7/2021

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.


Changed on 5/14/2021

VAERS ID: 611992 Before After
VAERS Form:1
Age:43.0
Sex:Female
Location:Unknown
Vaccinated:2015-10-15
Onset:2015-11-03
Submitted:2015-11-30
Entered:2015-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS NJ2S9 / 1 LA / SYR
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901 / 1 RA / SYR

Administered by: Other      Purchased by: Other
Symptoms: Injection site induration, Injection site pain, Lymph node pain, Lymphadenopathy, Paralysis, Injection site swelling, Extensive swelling of vaccinated limb

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK163564

Write-up: This case was reported by a other health professional via call center representative and described the occurrence of paralysis in a 43-year-old female patient who received BEXSERO (batch number 148901, expiry date 1st September 2016). Concomitant products included FLUARIX. On 15th October 2015, the patient received the 1st dose of BEXSERO. On 15th October 2015, 12 hrs after receiving BEXSERO, the patient experienced extensive swelling of vaccinated limb, injection site induration and injection site pain. On 3rd November 2015, the patient experienced paralysis (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis, extensive swelling of vaccinated limb, injection site induration and injection site pain were not recovered/not resolved. The reporter considered the paralysis to be possibly related to BEXSERO. The reporter considered the extensive swelling of vaccinated limb, injection site induration and injection site pain to be probably related to BEXSERO. Additional details were provided as follows: The reason patient was given BEXSERO was due to splenectomy. The patient also received FLUARIX on the same day but in separate arm. The health care professional reported that the patient received BEXSERO and within 12 hours the patient developed pain, swelling and an induration at the injection site. The swelling and pain increased to axillary lymph nodes. Also two and half weeks later patient at the time of reporting had paralysis of the pinky finger in arm where shot was given.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=611992&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166